Malignant neoplasm of other and ill-defined sites
- C76 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
- The 2025 edition of ICD-10-CM C76 became effective on October 1, 2024.
- This is the American ICD-10-CM version of C76 – other international versions of ICD-10 C76 may differ.
Type 1 Excludes
- malignant neoplasm of female genitourinary tract NOS (C57.9)
- malignant neoplasm of male genitourinary tract NOS (C63.9)
- malignant neoplasm of lymphoid, hematopoietic and related tissue (C81-C96 )
- malignant neoplasm of skin (C44.-)
- malignant neoplasm of unspecified site NOS (C80.1)
The following code(s) above C76 contain annotation back-references
that may be applicable to C76:
- C00-D49 Neoplasms
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
- 2024 (effective 10/1/2023): No change
- 2025 (effective 10/1/2024): No change
Code annotations containing back-references to C76:
- Applicable To: Z85.89